The National Treatment Agency’s (NTA) aspirational target is for each DAAT partnership to ensure that 100% of their previous/current injecting drug user (IDU) population to have been tested for Hepatitis C. Many DAATs across the country have struggled to achieve this target and Wirral DAAT’s performance at the end of 2007/08 is at 20%.
Resources
Drug services professional
Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country. Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.
Showing 241 to 248 of 248 resources
-
Wirral Drug and Alcohol Addiction Team (DAAT) Hep C Strategy
North West 2011 Case study, Strategy & Planning PDF -
Working Together to Reduce Harm (Substance Misuse) Delivery Plan 2016 - 2018
This Welsh Government delivery plan describes the work that will be undertaken reduce the harm caused by substance misuse. It includes actions related to hepatitis C such as the implementation of routine opt-out testing in substance misuse services.UK, Wales Sep 2016 Strategy & Planning PDF -
Workshop webinar: Hepatitis C in the justice system - going beyond prisons
This is a recording of a webinar covering initiatives to test and treat people for hepatitis C in contact with the justice system in England, held on the 23rd October 2020. Previous events and initiatives in this area have aimed to support people in prisons. Whilst this is important and continues, this webinar focused on new initiatives for people in contact with other areas of the justice system, such as probation services. The webinar featured 3 talks:North East, UK 29 Oct 2020 Case study, Strategy & Planning Video -
World Health Organisation (WHO) Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection
These are the first guidelines dealing with hepatitis C treatment produced by the World Health Organization (WHO) and complement existing guidance on the prevention of transmission of bloodborne viruses, including HCV. They are intended for policy-makers, government officials, and others working in low- and middle income countries who are developing programmes for the screening, care and treatment of persons with HCV infection.Rest of World Apr 2014 Tools & Templates, Strategy & Planning PDF -
World Hepatitis Alliance: 2019 Impact report
This report provides an overview of the World Hepatitis Alliance's impact in 2019, summarising key achievements in raising the importance of hepatitis elimination around the world.Rest of World 08 Apr 2020 Reports & Research PDF -
World Hepatitis Day 2018: Global Summary Report
This report, produced by the World Hepatitis Alliance, provides a comprehensive summary of international activity for World Hepatitis Day 2018. 144 countries, 93 governments and 53 WHO Country Offices took part across the six regions. Over 1,600 events were organised, 318,914 people attended events in their local community or country, and millions were reached online.UK, Rest of World 18 Dec 2018 Reports & Research PDF -
World Hepatitis Day 2019: Global Summary Report
The World Hepatitis Alliance has produced a report summarising activity for World Hepatitis Day 2019, including a global map of activity and regional reports.Rest of World 19 Dec 2019 Reports & Research PDF -
Yorkshire and the Humber Quality Standards Framework for Hepatitis B and C: 2012
In order to address the prevention and burden of hepatitis C (and B) effectively it is important that the four key elements of the pathway are in place as defined by the Department of Health. Whilst there have been many developments since 2004, this Quality Standards Framework still focuses on the four key elements of the hepatitis B and C pathway but provides more detail on how, in Yorkshire and the Humber, stakeholders can work effectively to deliver a quality pathway to patients regarding hepatitis B and C.Yorkshire and the Humber 2012 Other, Reports & Research PDF